Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid)

International Journal of Obesity

Volumn 25, Issue 7, 2001, Pages 1095-1099

  Cavaliere, H ^a   Floriano, I ^a   Medeiros Neto, G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gastrointestinal effects; Lipase inhibitor; Natural fibers; Obesity; Orlistat; Psyllium

Indexed keywords

PSYLLIUM HYDROCOLLOID; TETRAHYDROLIPSTATIN;

ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DIGESTIVE SYSTEM DISEASE; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; FECES INCONTINENCE; FEMALE; FIBER; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PAIN; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADULT; ANTI-OBESITY AGENTS; CROSS-OVER STUDIES; DIGESTIVE SYSTEM; FEMALE; HUMANS; LACTONES; OBESITY; PSYLLIUM;

EID: 0034969219     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801645     Document Type: Article

References (11)

1. A one year trial to assess the value of orlistat in the management of obesity
2. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
3. Orlistat, a lipase inhibitor, in the treatment of human obesity: A multiple dose study
4. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat
5. Current and potential drugs for treatment of obesity
6. Orlistat in the long-term treatment of obesity in primary care settings
7. Effects of psyllium hydrophillic mucilloid on LDL-cholesterol and bile acid synthesis in hypercholesterolemic men
8. Comparison of psyllium hydrophillic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia
9. Cholesterol-lowering effects of psyllium hydrophilic mucilloid
10. Low vs. high dietary fiber and serum, biliary and fecal lipids in middle-aged men